Macular thickness increases after cataract surgery

Article

Macular thickness significantly increases up to six months after uncomplicated cataract surgery, according to an investigation featured in the journal Eye.

Macular thickness significantly increases up to six months after uncomplicated cataract surgery, according to an investigation featured in the journal Eye.

Dr M. Gharbiya et al., Department of Ophthalmology, Sapienza University, Umberto I Hospital, Rome, Italy, conducted a prospective, non-randomized, clinical study on 40 patients undergoing uneventful phacoemulsification with fellow eyes used as controls.

OCT measurements were gathered before surgery and postoperatively at day 1, week 1 and 2 and month 1, 2, 3 and 6. The retinal map was split into central point thickness (CPT), central 1 mm subfield (CSF) and two peripheral ring areas with diametres of 3 and 6 mm.

Retinal thickness change between the fellow and operated eyes were compared using unpaired t-test and correlations were assessed using the Spearman or Pearson analysis.

The results revealed a progressive significant increase in retinal thickness in the operated eyes compared to the fellow eyes, peaking at one month for the 3 mm and 6 mm areas and at 2 months for CPT and CSF.

At six months retinal thickness was still significantly thicker than fellow eyes, but only in the peripheral areas. No significant correlations were recorded between macular thickness changes and preoperative factors, intraoperative factors or BCVA change. The most significant findings was the regional pattern of retinal thickening with an early involvement of the parafoveal area.

Please click here to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.